Francisella tularensis, the causative agent of tularemia, is classified as a Category A biological warfare agent by The Working Group on Civilian Biodefense because of its extreme infectivity, ease of dissemination, and substantial capacity to cause significant illness and death within a short period of time. Although aerosol-initiated F. tularensis infection is considered as the prime choice for a bioterrorist attack, deliberate contamination of drinking water and the food supply could be an alternative means to spread the infection. This approach would be especially attractive to non-state-supported individuals or groups of fanatical terrorists, who do not have the necessary equipment or technical expertise to generate an effective infectious aerosol. Most current research on F. tularensis has used a systemic infection model with the attenuated live vaccine strain (LVS) of F. tularensis. In contrast, very little is known about the pathogenesis of and immunity to virulent F. tularensis infections, especially following ingestion of the pathogen. Moreover, it is unknown whether or not the current live vaccine, F. tularensis LVS, is effective against oral infection with virulent F. tularensis in the event of food- and water- borne outbreaks because the mechanisms of host defense against type A F. tularensis infection initiated via different routes appear to be different. The primary goal of this R21 application in response to PA-03-080, """"""""Biodefense and Emerging Infectious Diseases Research Opportunities"""""""", is to develop and characterize a mouse model of oral infection with type A F. tularensis. Specifically, we aim to: 1) characterize the immunopathogenesis of oral infection with type A F. tularensis in mice; 2) determine the susceptibility of immunocompromised hosts to oral infection with type A F. tularensis; and 3) determine the effectiveness of LVS vaccine against oral infection with virulent F. tularensis. The mouse model developed and characterized under this R21 proposal will be a useful tool for future studies on the immune mechanisms of host defense against food- and water- borne tularemia and for the development and evaluation of effective vaccines and immunotherapeutic agents against virulent F. tularensis infection, the long-term objective of our research project. Results from this proposal will also provide valuable preliminary but fundamental information on the immunopathogenesis of oral F. tularensis infection so that future hypothesis-driven studies with more focused research objectives can be designed and developed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI059064-02
Application #
6927980
Study Section
Special Emphasis Panel (ZRG1-IDM-A (90))
Program Officer
Schaefer, Michael R
Project Start
2004-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$216,000
Indirect Cost
Name
National Research Council of Canada
Department
Type
DUNS #
City
Ottawa
State
ON
Country
Canada
Zip Code
Chen, Wangxue; Kuolee, Rhonda (2009) 6th Annual Vaccines: all things considered. Expert Rev Vaccines 8:281-4
Zhang, Deng; Kuolee, Rhonda; Harris, Greg et al. (2008) Lymphotoxin-alpha plays only a minor role in host resistance to respiratory infection with virulent type A Francisella tularensis in mice. Mediators Inflamm 2008:239740
KuoLee, Rhonda; Harris, Greg; Conlan, J Wayne et al. (2007) Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. Vaccine 25:3781-91
Miller, Harvey; Zhang, Jianbing; Kuolee, Rhonda et al. (2007) Intestinal M cells: the fallible sentinels? World J Gastroenterol 13:1477-86
KuoLee, R; Zhao, X; Austin, J et al. (2007) Mouse model of oral infection with virulent type A Francisella tularensis. Infect Immun 75:1651-60
Andersson, Henrik; Hartmanova, Blanka; Kuolee, Rhonda et al. (2006) Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis. J Med Microbiol 55:263-71
Twine, Susan M; Shen, Hua; Kelly, John F et al. (2006) Virulence comparison in mice of distinct isolates of type A Francisella tularensis. Microb Pathog 40:133-8
Chen, Wangxue; Kuolee, Rhonda; Austin, John W et al. (2005) Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion. Microb Pathog 39:189-96
Twine, Susan; Bystrom, Mona; Chen, Wangxue et al. (2005) A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 73:8345-52
Chen, Wangxue; Kuolee, Rhonda; Shen, Hua et al. (2005) Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with Francisella tularensis LVS. Immunol Lett 97:151-4